Evonik Aktie 18699457 / DE000EVNK013
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
|
05.02.2026 10:48:33
|
EQS-Adhoc: Evonik Industries AG: Executive Board adjusts dividend policy
|
EQS-Ad-hoc: Evonik Industries AG / Key word(s): Dividend payments Today, based on preliminary results for the fiscal year 2025 and the outlook for the fiscal year 2026, the Executive Board of Evonik Industries AG has decided to adjust the previous dividend policy. According to this, future payouts will range between 40 and 60 percent of the adjusted net income* to increase financial flexibility. This new dividend policy will be applied for the first time to the distribution of the profit for the fiscal year 2026. For the fiscal year 2025, the Executive Board will propose to the Annual General Meeting a dividend of €1.00 per share as a transition to the new dividend policy. This currently corresponds to a dividend yield of about 7 percent. Previously, €1.17 per share had been paid as dividend. The new dividend policy aims to achieve an improved balance between an appropriate profit-sharing for shareholders and Evonik's financial flexibility. Based on preliminary, unaudited figures, Evonik achieved an adjusted EBITDA* of approximately €1.874 billion in the past fiscal year 2025, with sales of approximately €14.1 billion, a cash conversion rate* of approximately 37%, and a free cash flow* of around €695 million. The economic environment remains challenging in 2026. Therefore, Evonik expects an adjusted EBITDA* between €1.7 and €2.0 billion for the current fiscal year. Evonik Industries AG intends to publish final figures for the fiscal year 2025, including the dividend proposal from the Executive Board and Supervisory Board, on 4 March 2026, as planned. *Notes on the key performance indicators (KPIs) used can be found in the Financial and Sustainability Report 2024 of Evonik Industries AG starting on page 322. The Financial and Sustainability Report 2024 is available at: https://evonik.finance/financial-and-sustainablity-report-2024
Contact/person making the notification: End of Inside Information
05-Feb-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Evonik Industries AG |
| Rellinghauser Strasse 1-11 | |
| 45128 Essen | |
| Germany | |
| Phone: | +49 (0) 201 177-01 |
| Fax: | +49 (0) 201 177-3475 |
| E-mail: | investor-relations@evonik.com |
| Internet: | www.evonik.com |
| ISIN: | DE000EVNK013 |
| WKN: | EVNK01 |
| Indices: | MDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX; Luxembourg Stock Exchange |
| EQS News ID: | 2271992 |
| End of Announcement | EQS News Service |
|
|
2271992 05-Feb-2026 CET/CEST
Nachrichten zu Evonik AG
|
17:58 |
Schwacher Handel: MDAX beendet die Sitzung im Minus (finanzen.ch) | |
|
15:58 |
Minuszeichen in Frankfurt: MDAX zeigt sich am Donnerstagnachmittag leichter (finanzen.ch) | |
|
14:25 |
KORREKTUR: Evonik-Dividende für 2026 wird nochmals niedriger ausfallen (Dow Jones) | |
|
14:21 |
Evonik senkt Dividende - Hält 2026 Gewinnbelebung für möglich (AWP) | |
|
12:26 |
Anleger in Frankfurt halten sich zurück: MDAX notiert im Minus (finanzen.ch) | |
|
11:34 |
Evonik-Aktie gewinnt: Operatives Ergebnis fällt unter Vorjahreswert, Netto steigt (Dow Jones) | |
|
11:09 |
Evonik passt Dividendenpolitik an (Dow Jones) | |
|
10:48 |
EQS-Adhoc: Evonik Industries AG: Vorstand passt Dividendenpolitik an (EQS Group) |
Analysen zu Evonik AG
| 13:04 | Evonik Equal Weight | Barclays Capital | |
| 12:37 | Evonik Sell | Goldman Sachs Group Inc. | |
| 11:53 | Evonik Underperform | Jefferies & Company Inc. | |
| 16.01.26 | Evonik Neutral | JP Morgan Chase & Co. | |
| 16.01.26 | Evonik Equal Weight | Barclays Capital |
3 Knaller-Aktien im BX Musterportfolio: KLA, Alphabet & BBVA mit François Bloch
Im BX Morningcall werden folgende Aktien analysiert und erklärt
✅ KLA
✅ Alphabet A
✅ BBVA (Banco Bilbao Vizcaya Argentaria)
https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
EZB-Zinsentscheid im Fokus: SMI schliesst schwächer -- DAX geht tiefer aus dem Handel -- Asiens Börsen letztlich mehrheitlich im MinusSowohl der heimische als auch der deutsche Aktienmarkt steckten Verluste ein. Der Dow zeigt sich erneut mit Abgaben. Die Börsen in Fernost wiesen am Donnerstag grösstenteils rote Vorzeichen aus.


